欧洲股市在周一出现微幅下跌，主要股指表现平淡。斯托克600指数收盘下跌0.2%，投资者对即将召开 的美联储政策会议保持谨慎观望态度。 市场普遍预期美联储将在本周的货币政策会议上宣布降息25个基点。据芝商所美联储观察工具显示，交 易员目前定价12月降息的概率约为85%。这一预期为全球金融市场带来不确定性，促使投资者在重要决 议前采取观望策略。 科技股和金融股成为欧洲股市的主要拖累因素。与此同时，旅游与休闲板块以及矿业板块表现相对较 好。个股方面，诺和诺德股价下跌5.8%，此前该公司宣布其口服版药物在阿尔茨海默病研究中未能达 到预期效果。 货币市场方面，美元在美联储会议前走低，欧元需求有所上升。投资者正在为本周多家全球央行的关键 决策做准备，其中美联储会议被视为最重要的事件。 金融监管政策的调整为市场带来新的流动性预期。相关部门下调了保险资金投资股票的风险因子，这释 放出增量资金入市的积极信号。 展望后市，分析师认为美联储的政策决定将为全球货币政策定下基调。瑞士央行、英国央行、欧洲央行 和日本央行在12月下旬的政策路径可能受到美联储决议结果的影响。 声明：市场有风险，投资需谨慎。本文为AI基于第三方数据生成，仅供 ...

2022年，相关部门曾发布管理办法，规定商业银行等金融机构为自然人客户办理人民币单笔5万元以上 现金存取时，应当识别并核实客户身份，了解并登记资金的来源或者用途。这一规定在当时引发了社会 广泛关注，公众意见呈现分歧。银行方面表示基于反诈风控要求进行询问，而用户经常不满银行机构在 业务办理中询问过多过细，质疑其涉嫌侵犯隐私。 最新《管理办法》直接将这条规定删除，未再要求登记资金来源和用途，同时明确仅在出现较高洗钱风 险时，银行才需强化调查，了解资金来源和用途；对低风险业务则可采取简化措施。这意味着，未来银 行将根据客户风险状况动态调整审核方式，不再对每位储户"一刀切"询问，普通用户也无需再为合规取 款而"自证清白"。 本报讯（记者 潘福达）人民银行、国家金融监管总局、证监会近日联合发布《金融机构客户尽职调查 和客户身份资料及交易记录保存管理办法》，其中取消了"个人存取现金超5万元需登记资金来源"的规 定，与此前征求意见稿保持一致。该办法将于2026年1月1日起正式施行。 ...

Core Viewpoint - The company has decided to deregister its subsidiary, Yuhe Financial Services Co., Ltd., due to changes in financial regulations that have rendered its original business model unsustainable [2][3]. Group 1: Company Decision - The company announced the decision to deregister Yuhe Financial, in which it holds a 20% stake with an investment of 10 million yuan [1]. - Yuhe Financial was established in June 2016 and primarily served small and medium-sized enterprises in Xianju County [1]. Group 2: Impact of Financial Policy Changes - The original business operations of Yuhe Financial, focused on loan turnover for small and medium enterprises, have ceased due to ongoing adjustments in financial regulatory policies [2]. - Regulatory authorities have mandated that Yuhe Financial either change its business scope or cease operations, leading to the decision for dissolution and liquidation [2]. Group 3: Operational Independence - The company clarified that it has not provided any guarantees, financial support, or entrusted financial services to Yuhe Financial, indicating a low level of operational interdependence [4]. - The deregistration will not affect the company's main business operations, which focus on the research, production, and sales of steroid raw materials and formulations across four major categories: corticosteroids, sex hormones, anesthetics, and respiratory drugs [4]. - The deregistration process does not involve any personnel placement issues and will not impact the company's ongoing profitability [4].

Group 1 - The financial regulatory authority in Taiwan has announced the resumption of daily intraday short-selling orders, the minimum margin requirement for short selling, and the relaxation of collateral requirements [1]